A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment
Status:
Recruiting
Trial end date:
2023-02-07
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to determine the pharmacokinetics (PK) following a single
oral dose administration of brensocatib, safety, and tolerability of brensocatib when
administered to participants with impaired renal function and in healthy participants.